• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 35MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 35MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number 0008021480
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729); Tachycardia (2095)
Event Date 01/25/2024
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
Pf114 faradise clinical study, subject id: (b)(4).It was reported that after an irreversible electroporation ablation procedure using a farawave catheter to treat atrial fibrillation (a fib) the patient presented to the emergency room with re-occurrent atrial fibrillation (a fib).When the a fib was identified, the patient was admitted to the hospital and a cardioversion was performed to restore the sinus rhythm.Supraventricular tachycardia was seen for eight beats after the shock before the patient's rhythm normalized.They were discharged from the hospital that same day.The catheter is not expected to be returned as the complication emerged after the procedure, when the catheter would have been discarded.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
(b)(6) faradise clinical study, subject id: (b)(6).It was reported that after an irreversible electroporation ablation procedure using a farawave catheter to treat atrial fibrillation (a fib) the patient presented to the emergency room with re-occurrent atrial fibrillation (a fib).When the a fib was identified, the patient was admitted to the hospital and a cardioversion was performed to restore the sinus rhythm.Supraventricular tachycardia was seen for eight beats after the shock before the patient's rhythm normalized.They were discharged from the hospital that same day.The catheter is not expected to be returned as the complication emerged after the procedure, when the catheter would have been discarded.It was further reported that a repeat ablation for the a fib reoccurrence took place two months later.They were hospitalized overnight for the procedure, which was completed with no further patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER, 35MM
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer (Section G)
AGILE MV INC
3700 st patrick st suite 102
montreal, qc H4E 1 A2
CA   H4E 1A2
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18712661
MDR Text Key335527695
Report Number2124215-2024-09042
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number0008021480
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/06/2024
Initial Date FDA Received02/15/2024
Supplement Dates Manufacturer Received04/19/2024
Supplement Dates FDA Received05/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age68 YR
Patient SexMale
Patient Weight69 KG
-
-